However, it is not yet known whether the expressions of Dok1 and BRK in breast cancers are regulated epigenetically via promoter hypermethylation; although, there is evidence of BRK promoter hypomethylation in cisplatin resistant ovarian cancer cells [89]. This evidence concerns the gene PTK6 and ovarian cancer.